# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001493152-21-031411
Filing Date
2021-12-14
Accepted
2021-12-14 16:30:02
Documents
30
Period of Report
2021-12-14
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 |  | form8-k.htm iXBRL | 8-K | 35134
2 |  | ex99-1.htm | EX-99.1 | 15090
3 |  | ex99-1_001.jpg | GRAPHIC | 107822
4 |  | ex99-1_002.jpg | GRAPHIC | 331249
5 |  | ex99-1_003.jpg | GRAPHIC | 133345
6 |  | ex99-1_004.jpg | GRAPHIC | 145469
7 |  | ex99-1_005.jpg | GRAPHIC | 122277
8 |  | ex99-1_006.jpg | GRAPHIC | 133326
9 |  | ex99-1_007.jpg | GRAPHIC | 145953
10 |  | ex99-1_008.jpg | GRAPHIC | 117255
11 |  | ex99-1_009.jpg | GRAPHIC | 177649
12 |  | ex99-1_010.jpg | GRAPHIC | 112222
13 |  | ex99-1_011.jpg | GRAPHIC | 193522
14 |  | ex99-1_012.jpg | GRAPHIC | 145623
15 |  | ex99-1_013.jpg | GRAPHIC | 63876
16 |  | ex99-1_014.jpg | GRAPHIC | 140709
17 |  | ex99-1_015.jpg | GRAPHIC | 135238
18 |  | ex99-1_016.jpg | GRAPHIC | 129822
19 |  | ex99-1_017.jpg | GRAPHIC | 61257
| Complete submission text file | 0001493152-21-031411.txt |  | 3525248

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
20 | XBRL SCHEMA FILE | ocx-20211214.xsd | EX-101.SCH | 3022
21 | XBRL LABEL FILE | ocx-20211214_lab.xml | EX-101.LAB | 34240
22 | XBRL PRESENTATION FILE | ocx-20211214_pre.xml | EX-101.PRE | 22358
23 | EXTRACTED XBRL INSTANCE DOCUMENT | form8-k_htm.xml | XML | 3570

Mailing Address 15 CUSHING IRVINE CA 92618
Business Address 15 CUSHING IRVINE CA 92618 949-409-7600
Oncocyte Corp (Filer) CIK: 0001642380 (see all company filings)

EIN.: 271041563 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37648 | Film No.: 211491307
SIC: 2835 In Vitro & In Vivo Diagnostic Substances